Aprinoia Therapeutics
PrivateLast Round
Grant
Sep 11, 2023
Total Funding Raised
$55.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Aprinoia Therapeutics is a biotechnology company that develops diagnostic tools and therapeutics for a broad range of neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Imaging, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aprinoia Therapeutics Comparables
Compare Aprinoia Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lantheus Holdings Inc. | 80% | |
| AC Immune SA | 79% | |
| Roche Holding | 78% |
Aprinoia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 11, 2023 | ||||
| Series C | Dec 28, 2021 | ||||
| Series B | Jan 16, 2018 | ||||
| Seed | May 1, 2015 |
Aprinoia Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TaiAn Technologies Corp. | Series B, Series C |
| IMM Investment | Series C |
| DCI Partners | Series A, Series B |
| Harvest Capital (Suzhou Industrial Park) | Series C |
| ShangPharma Innovation | Series B |
| Daol Investment | Series A, Series C, Series B |
| National Development Fund | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 367% MoM.
- Jan 26, 2026
Monthly visitors grew 648% MoM, from 668 to 5K.
Aprinoia Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aprinoia Therapeutics's valuation, stock price, and market status.
Is Aprinoia Therapeutics a public or private company?
Aprinoia Therapeutics is a private company.
What is the current stock price of Aprinoia Therapeutics?
Aprinoia Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Aprinoia Therapeutics worth (valuation)?
Valuation information for Aprinoia Therapeutics is not publicly available.
Can I buy Aprinoia Therapeutics stock?
Aprinoia Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aprinoia Therapeutics's last funding round?
Aprinoia Therapeutics's most recent funding round was Grant on September 11, 2023.
Who are the main investors in Aprinoia Therapeutics?
Key investors in Aprinoia Therapeutics include DCI Partners, Daol Investment.
Will Aprinoia Therapeutics IPO soon?
No public IPO plans have been announced for Aprinoia Therapeutics.
How can I track Aprinoia Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aprinoia Therapeutics's secondary market activity and sign up for updates.